Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Policy & Regulation
Trends & Finance
Agreement
Flatiron Health, Guardant Health to integrate tests, EMR platform
Flatiron Health and Guardant Health have signed an agreement to integrate Guardant’s genomic profiling test portfolio into Flatiron’s cloud-based OncoEMR electronic medical record (EMR) platform.
November 1, 2023
Astellas snags chance to license Poseida cell therapy in $50M deal
The agreement gives Astellas first refusal for partnering on P-MUC1C-ALLO1, an allogeneic chimeric antigen receptor (CAR) T cell therapy product candidate that Poseida is developing as a treatment for solid tumors.
August 9, 2023
Guardant and Illumina resolve lawsuit, reach agreement
In a statement, Guardant said the “three-year agreement includes a joint request to dismiss with prejudice the pending litigation between the companies.” The request to dismiss includes “any allegations related to the subject intellectual property.”
August 7, 2023
Siemens Healthineers to distribute Scopio Labs’ full-field digital cell morphology technology
Siemens Healthineers said the Scopio X100 and Scopio X100HT imaging platforms will complement its IVD systems, including the Atellica Hema 570 and Atellica Hema 580 analyzers.
May 8, 2023
Werfen signs distribution agreement with Thermo Fisher for hemostasis diagnostics system
The exclusive, long-term agreement allows Barcelona-based Werfen to continue offering the HemoCell Specialized Lab Automation system.
May 4, 2023
Agilent Technologies, Proscia ink digital pathology distribution agreement
Combining Agilent's pathology staining solutions with Proscia’s Concentriq Dx enterprise pathology platform will empower pathology labs to transform diagnostic efficiency and quality, Agilent said.
March 8, 2023
Exact Sciences executes private placement of convertible senior notes
Under the agreement, Exact Sciences has agreed to issue to the holder $500 million aggregate principal amount of a new series of 2% convertible senior notes due in 2030.
February 23, 2023
Quest Diagnostics, New York-Presbyterian ink laboratory services agreement
Their strategic objective is to broaden access to laboratory services for providers in New York, Connecticut, New Jersey, and beyond.
February 14, 2023
S2 Genomics, Bonsailab ink Spain, Portugal distribution agreement
S2 Genomics is partnering with Bonsailab to promote, sell, and support its Singulator 100 and 200 systems, which provide consistent isolation of single cells or nuclei from solid-tissue samples.
January 17, 2023
T2 Biosystems nabs contract extension with group purchasing organization
Products covered under the contract with Vizient, a purchasing organization for healthcare institutions, include the T2Dx Instrument, T2Bacteria Panel, and T2Candida Panel. All detect sepsis-causing bacterial and fungal pathogens from whole blood.
December 28, 2022
Source LDPath, Ibex Medical Analytics ink agreement to deploy AI-enabled pathology platform
AI-enabled tools will be used to diagnose multiple tissue types and improve diagnostic accuracy and efficiency, Source LDPath said.
December 7, 2022
Quest Diagnostics, Premier ink laboratory stewardship platform and services agreement
Premier members can obtain specific negotiated pricing and terms to access Quest's laboratory stewardship solution.
December 1, 2022
Page 1 of 16
Next Page
